Clinical Perspectives

Alpha-Gal Syndrome is often described as a food allergy, yet clinicians quickly recognize that two patients with the same diagnosis can have remarkably different experiences. Some react to trace exposures while others tolerate small amounts of mammalian products. Some struggle primarily with gastrointestinal symptoms, while others experience skin, respiratory, neurological, or systemic reactions. Laboratory findings alone do not fully explain this clinical variability.

After more than a decade of caring for individuals living with Alpha-Gal Syndrome, I have repeatedly found myself asking the same question: Why do two patients with the same diagnosis experience this condition so differently?

Rather than viewing Alpha-Gal Syndrome as an isolated diagnosis, the framework considers the broader health landscape each individual brings to the condition. These observations are offered as a conceptual framework and clinical hypothesis intended to stimulate discussion and future research, not to establish causation.

The purpose of this paper is not to redefine Alpha-Gal Syndrome but to encourage clinicians to look beyond the diagnosis itself. By considering the individual patient alongside the condition, we may gain a broader understanding of the remarkable variability observed in clinical practice and identify new avenues for research and patient education.

© 2026 Cindy Rhoday-Murphy, L.Ac.

This article introduces an original conceptual hypothesis developed through the author’s professional experience, observations, and conversations surrounding Alpha-Gal Syndrome.